Results 21 to 30 of about 757 (98)

Rare forms of cerebral amyloid angiopathy: pathogenesis, biological and clinical features of CAA-ri and iCAA

Frontiers in Neuroscience, 2023
Thanks to a more widespread knowledge of the disease, and improved diagnostic techniques, the clinical spectrum of cerebral amyloid angiopathy (CAA) is now broad.
Benedetta Storti, Maria Magdalena Gabriel, Maria Magdalena Gabriel, Stefan Sennfält, Isabella Canavero, Nicola Rifino, Laura Gatti, Anna Bersano   +7 more
doaj   +3 more sources

Cerebrospinal fluid biomarkers in cerebral amyloid angiopathy: insights from a clinical case series [PDF]

Arquivos de Neuro-Psiquiatria
Cerebral amyloid angiopathy (CAA) is a small vessel disease characterized by the deposition of amyloid-beta in small cerebral vessels, which can lead to intracerebral hemorrhages and cognitive impairment.
Ana Silvia Sobreira Lima Verde, Alessandra Braga Cruz Guedes de Morais, Amanda Vale Catunda, João Igor Dantas Landim, Ian Silva Ribeiro, Bruno Diógenes Iepsen, Norberto Anízio Ferreira Frota   +6 more
doaj   +2 more sources

Iatrogenic cerebral amyloid angiopathy: two new cases and systematic review of case reports with neuropathological data [PDF]

Neurological Research and Practice
Awareness concerning iatrogenic cerebral amyloid angiopathy (iCAA) is increasing but its pathophysiology remains unclear. We discuss the implications of the clinical, imaging and neuropathological findings in two previously unpublished cases of probable ...
Ana Sofia Costa, João Pinho, Arno Reich, Omid Nikoubashman, Kay Nolte, Joachim Weis, Christian Boy, Felix M. Mottaghy, Jörg B. Schulz, Kathrin Reetz   +9 more
doaj   +2 more sources

CSF and Plasma Biomarkers in Patients With Iatrogenic Cerebral Amyloid Angiopathy. [PDF]

Neurology
Recently, a subset of patients affected by cerebral amyloid angiopathy (CAA) distinguished by atypical juvenile onset and a hypothesized iatrogenic origin (iatrogenic CAA, iCAA) has emerged. β-Amyloid (Aβ) accumulation evidenced by amyloid PET positivity or CSF Aβ decrease was included in the iCAA diagnostic criteria.
Pollaci G, Potenza A, Gorla G, Carrozzini T, Marinoni G, De Toma C, Canavero I, Rifino N, Boncoraglio GB, Difrancesco JC, Damavandi PT, Stanziano M, Erbetta A, Caroppo P, Di Fede G, Catania M, Zulueta A, Parati EA, Bersano A, Gatti L, Storti B.   +20 more
europepmc   +5 more sources

Iatrogenic cerebral amyloid angiopathy: An illustrative case of a newly introduced disease

European Journal of Neurology, 2023
AbstractBackground and purposeIatrogenic cerebral amyloid angiopathy (iCAA) is a specific type of cerebral amyloid angiopathy which is becoming increasingly diagnosed. It has been hypothesized that iCAA might arise as a late consequence of past neurosurgical interventions involving dural patch grafts.
Benedetta Storti, Anna Bersano
exaly   +3 more sources

Iatrogenic cerebral amyloid angiopathy with inflammatory pathogenesis: A case report and literature review. [PDF]

Surg Neurol Int
Background: Iatrogenic cerebral amyloid angiopathy (iCAA) is a rare form of amyloid β (Aβ)-mediated small vessel disease associated with prior neurosurgical exposure, such as cadaveric dura mater grafting or other Aβ-contaminated materials.
Miyaoka R, Nishizawa S, Tanaka Y, Yamamoto J.   +3 more
europepmc   +3 more sources

Amyloid-β pathology and cerebral amyloid angiopathy are frequent in iatrogenic Creutzfeldt-Jakob disease after dural grafting

Swiss Medical Weekly, 2016
QUESTIONS UNDER STUDY: Alzheimer-type amyloid-β (Aβ) pathology was reported in brains of individuals developing iatrogenic Creutzfeldt-Jakob disease (iCJD) after treatment with human cadaveric growth hormone, and interpreted as evidence of human ...
Karl Frontzek, Mirjam I. Lutz, Adriano Aguzzi, Gabor G. Kovacs, Herbert Budka   +4 more
doaj   +4 more sources

ABSTRACT NUMBER: ESOC2026A1784 LONG-TERM OUTCOME OF PATIENTS WITH IATROGENIC CEREBRAL AMYLOID ANGIOPATHY [PDF]

Eur Stroke J
Abstract Background and aims Iatrogenic cerebral amyloid angiopathy (iCAA) has emerged as a rare but distinct CAA subtype, with increasing recognition worldwide. However, information on long-term prognosis remains limited. Methods
Simon Fandler-Höfler, Benedetta Storti, Kanishk Kaushik, Larysa Panteleienko, Slaven Pikija, Payam Tabaee Damavandi, Anna Bersano, Marieke Wermer, Gargi Banerjee, David Werring   +9 more
europepmc   +2 more sources

Medicolegal aspects of iatrogenic cerebral amyloid angiopathy. [PDF]

Surg Neurol Int
Jensen-Kondering U.
europepmc   +2 more sources

Diagnosis, pathomechanisms and therapy of cerebral amyloid angiopathy-related inflammation (CAA-ri) [PDF]

Neurological Research and Practice
Background Research of the past years has refined our perception of cerebral amyloid angiopathy-related inflammation (CAA-ri) as a subacute autoimmune encephalopathy, which is presumably caused by elevated CSF concentrations of anti-amyloid β (Aβ ...
Rebecca M. Seifert, Randolf Klingebiel, Wolf-Rüdiger Schäbitz   +2 more
doaj   +2 more sources